Building a ‘Repository of Science’: The importance of integrating biobanks within molecular pathology programmes

European Journal of Cancer

Volumn 67, Issue , 2016, Pages 191-199

  Lewis, Claire ^a   McQuaid, Stephen ^a,b   Hamilton, Peter W ^a   Salto Tellez, Manuel ^a,b   McArt, Darragh ^a   James, Jacqueline A ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Biobank; Digital pathology; Informatics; Molecular diagnostics; Molecular pathology; Tissue bank

Indexed keywords

BIOBANK; DIGITAL IMAGING; FORMALIN FIXED PARAFFIN EMBEDDING; GENOTYPING TECHNIQUE; HISTOLOGY; HUMAN; INCIDENTAL FINDING; LABORATORY INFORMATION SYSTEM; MOLECULAR DIAGNOSIS; MOLECULAR PATHOLOGY; NEXT GENERATION SEQUENCING; NORTHERN IRELAND; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; TISSUE MICROARRAY; TRANSLATIONAL RESEARCH; TUMOR BIOPSY; CHEMICAL DATABASE; COOPERATION; GENETIC DATABASE; INFORMATION SCIENCE; MEDICAL RESEARCH; METABOLISM; NEOPLASM; PERSONALIZED MEDICINE;

TUMOR MARKER;

BIOLOGICAL SPECIMEN BANKS; BIOMARKERS, TUMOR; BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; DATABASES, CHEMICAL; DATABASES, GENETIC; HUMANS; INFORMATICS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; NORTHERN IRELAND; PATHOLOGY, MOLECULAR; PRECISION MEDICINE;

EID: 84988485952     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2016.08.009     Document Type: Review

References (36)

1. [1] Hanash, S.M., Pitteri, S.J., Faca, V.M., Mining the plasma proteome for cancer biomarkers. Nature 452 (2008), 571–579.
2. [2] Mardis, E.R., The impact of next-generation sequencing technology on genetics. Trends Genet 24 (2008), 133–141.
3. [3] Adams, K., Martin, S., Ethical tissue: a not-for-profit model for human tissue supply. Cell Tissue Bank 12 (2011), 9–10.
4. [4] Hewitt, R., Biobanking: the foundation of personalized medicine. Curr Opin Oncol 23 (2011), 112–119.
5. [5] Salto-Tellez, M., James, J.A., Hamilton, P.W., Molecular pathology – the value of an integrative approach. Mol Oncol 8 (2014), 1163–1168.
6. [6] McDonald, S.A., Watson, M.A., Rossi, J., Becker, C.M., Jaques, D.P., Pfeifer, J.D., A new paradigm for biospecimen banking in the personalized medicine era. Am J Clin Pathol 136 (2011), 679–684.
7. [7] de Leng, W.W.J., Gadellaa-van Hooijdonk, C.G., Barendregt-Smouter, F.A.S., Koudijs, M.J., Nijman, L., Hinrichs, J.W.J., et al. Targeted next generation sequencing as a reliable diagnostic assay for the detection of somatic mutations in tumours using minimal DNA amounts from formalin fixed paraffin embedded material. PLoS One, 2016, 10.1371/journal.pone.0149405 eCollection 2016.
8. [8] Spencer, D.H., Sehn, J.K., Abel, H.J., Watson, M.A., Pfeifer, J.D., Duncavage, E.J., Comparision of clinical targeted next-generation sequence data from formalin fixed and fresh frozen tissue specimens. J Mol Diagn 15 (2013), 623–633.
9. [9] Kokkat, T.J., Patel, M.S., McGarvey, D., LiVolsi, V.A., Baloch, Z.W., Archived formalin-fixed paraffin-embedded (FFPE) blocks: a valuable underexploited resource for extraction of DNA, RNA, and protein. Biopreserv Biobank 11 (2013), 101–106.
10. [10] Adema, V., Torres, E., Sole, F., Serrano, S., Bellosillo, B., Paraffin treasures: do they last forever?. Biopreserv Biobank 12 (2014), 281–283.
11. [11] Issag, H.J., Waybright, T.J., Veenstra, T.D., Cancer biomarker discovery: opportunities and pitfalls in analytical methods. Electrophoresis 32 (2011), 967–975.
12. [12] Confederation of Cancer Biobanks UK, Collecting, storing and providing human biological material and data for research. 2014 http://ccb.ncri.org.uk/biobanking/harmonisation-and-benchmarking.
13. [13] Quinlan, P.R., Mistry, G., Bullbeck, H., Carter, A., Confederation of Cancer Biobanks (CCB) Working Group 3. A data standard for sourcing fit-for-purpose biological samples in an integrated virtual network of biobanks. Biopreserv Biobank 12 (2014), 184–191.
14. [14] Reichel, J., Lind, A., Hansson, M.G., Litton, J.E., ERIC: a new governance tool for biobanking. Eur J Hum Genet 22 (2014), 1055–1057.
15. [15] Quinlan, P.R., Groves, M., Jordan, L.B., Stobart, H., Purdie, C.A., Thompson, A.M., The informatics challenges facing biobanks: a perspective from a United Kingdom Biobanking Network. Biopreserv Biobank 13 (2015), 363–369.
16. [16] Asslaber, M., Zatloukal, K., Biobanks: transnational, European and global networks. Brief Funct Genomics Proteomics 6 (2007), 193–201.
17. [17] Shaw, P.M., Patterson, S.D., The value of banked samples for oncology drug discovery and development. J Natl Cancer Inst Monogr 42 (2011), 46–49.
18. [18] Suh, K.S., Sarojini, S., Youssif, M., Nalley, K., Milinovikj, N., Elloumi, F., et al. Tissue banking, bioinformatics and electronic medical records: the front end requirements for personalized medicine. J Oncol, 2013, 368751, 10.1155/2013/368751.
19. [19] McArt, D., Blayney, J., Boyle, D., Irwin, G., Moran, M., Hutchinson, R., et al. PICan: an integromics framework for dynamic cancer biomarker discovery. Mol Oncol 9 (2015), 1234–1240.
20. [20] Li, G., Bankhead, P., Dunne, P., O'Reilly, P.G., James, J.A., Salto-Tellez, M., et al. Embracing an integromic approach to tissue biomarker research in cancer: perspectives and lessons learned. Brief Bioinforma, 2016, 10.1093/bib/bbw044 epub ahead of print.
21. [21] Roychowdhury, S., Iyer, M.K., Robinson, D.R., Lonigro, R.J., Wu, Y.M., Cao, X., et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med, 3, 2011, 111ra121.
22. [22] McCourt, C.M., McArt, D.G., Mills, K., Catherwood, M.A., Maxwell, P., Waugh, D.J., et al. Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis. PLoS One, 8, 2013, e69604.
23. [23] Wolf, S.M., Lawrenz, F.P., Nelson, C.A., Kahn, J.P., Cho, M.K., Clayton, E.W., et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics 36 (2008), 219–248.
24. [24] Souzeau, E., Burdon, K.P., Mackey, D.A., Hewitt, A.W., Savarirayan, R., Otlowski, M., et al. Ethical considerations for the return of incidental findings in ophthalmic genomic research. Transl Vis Sci Technol 5 (2016), 1–11.
25. [25] Levy, B.P., McClintock, D.S., Lee, R.E., Lane, W.J., Klepeis, V.E., Baron, J.M., et al. Different tracks for pathology informatics fellowship training: experiences of and input from trainees in a large multisite fellowship program. J Pathol Inf, 3, 2012, 30.
26. [26] Ogino, S., King, E.E., Beck, A.H., Sherman, M.E., Milner, D.A., Giovannucci, E., Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol 176 (2012), 659–667.
27. [27] Hamilton, P.W., Bankhead, P., Wang, Y., Hutchinson, R., Kieran, D., McArt, D.G., et al. Digital pathology and image analysis in tissue biomarker research. Methods 70 (2014), 59–73.
28. [28] Ghaznavi, F., Evans, A., Madabhushi, A., Feldman, M., Digital imaging in pathology: whole slide imaging and beyond. Annu Rev Pathol Mech Dis 8 (2013), 331–359.
29. [29] Bevilacqua, G., Bosman, F., Dassesse, T., Hofler, H., Janin, A., Langer, R., et al. The role of the pathologist in tissue banking: European consensus expert group report. Virchows Arch 456 (2010), 449–454.
30. [30] Vaught, J., Rogers, J., Myers, K., Lim, M.D., Lockhart, N., Moore, H., et al. An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr 42 (2011), 1–7.
31. [31] Reigman, P.H.J., Morente, M.M., Betsou, F., de Blasio, P., Geary, P., Biobanking for better healthcare. Mol Oncol 2 (2008), 213–222.
32. [32] Betsou, F., Rimm, D.L., Watson, P.H., Womack, C., Hubel, A., Coleman, R.A., et al. What are the biggest challenges and opportunities for biorepositories in the next three to five years?. Biopreserv Biobank 8 (2010), 81–88.
33. [33] Esposito, A., Criscitiello, C., Lacatelli, M., et al. Liquid biopsies for solid tumours: understanding tumour heterogeneity and real time monitoring of early resistance to targeted therapies. Pharmacol Ther, 2015; Nov 23.
34. [34] Sadovska, L., Eglitis, J., Line, A., Extracellular vesicles as biomarkers and therapeutic targets in breast cancer. Anticancer Res 35 (2015), 6379–6390.
35. [35] Ngo, C., Samuels, S., Bagrintseva, K., Slocker, A., Hupe, P., Kenter, G., et al. From prospective biobanking to precision medicine: BIO-RAIDs—an EU study protocol in cervical cancer. BMC Cancer, 15, 2015, 842, 10.1186/s12885-015-1801-0.
36. [36] Watson, R.W.G., Kay, E.W., Smith, D., Intergrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research. Nat Rev Cancer 10 (2010), 646–651.